Skip to main content
Equibles

Abraham Bassan

Rani Therapeutics Holdings, Inc. (RANI)

Board Member

Rani Therapeutics Holdings, Inc. (RANI)

Equibles does not estimate personal net worth.

Get an email with a short summary when Rani Therapeutics Holdings, Inc. publishes a filing, an earnings call transcript or a press release.

Get RANI alerts

About Abraham Bassan

Abraham Bassan is recorded as Board Member at Rani Therapeutics Holdings, Inc. (RANI) since October 27, 2025. Abraham Bassan was last confirmed as Board Member at LENZ Therapeutics, Inc. (LENZ) in a filing dated June 6, 2023. Abraham Bassan was last confirmed as Board Member at Septerna, Inc. (SEPN) in a filing dated April 29, 2025. Rani Therapeutics Holdings, Inc. reported in an 8-K filed October 27, 2025 that Abraham Bassan was appointed member of the Board, effective October 23, 2025. Rani Therapeutics Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rani Therapeutics Holdings, Inc. includes Lisa Rometty (CEO), Talat Imran (CEO and Board Member), Mir Imran (Chairman) and 7 others.

“On October 22, 2025, upon the recommendation of the Nominating and Corporate Governance Committee, each of Abraham Bassan and Vasudev Bailey, Ph.D., was appointed to the Board, effective upon the closing of the Private Placement, until the earlier of the Company's next annual meeting of stockholders, the appointment and qualification of his successor, or his death, resignation, or removal (the "Appointments").”
Rani Therapeutics Holdings, Inc. Form 8-K, filed October 27, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Rani Therapeutics Holdings, Inc.

Recent activity